Guardant Health (GH) investors have a new number to think about this week. Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Morgan Stanley unveils key Monster stock price prediction | 6 | 7 | 04-07-2026 |
| 2 | Goldman Sachs doubles down on Robinhood stock after record trading surge | 7 | 8 | 05-07-2026 |
| 3 | Top Analyst strongly resets AMD stock price target | 5 | 7 | 05-07-2026 |
| 4 | Top analyst has bold Costco stock outlook for 2026 | 0 | 5 | 05-07-2026 |
| 5 | Concentra Group Holdings Parent (NYSE:CON) Given New $42.00 Price Target at Royal Bank Of Canada | 0 | 9.62 | 10-08-2026 |
| 6 | Royal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00 | 0 | 10.54 | 10-08-2026 |
| 7 | Warren Buffett unveils 11-word stock market warning | 0 | 5 | 05-07-2026 |
| 8 | Why Palantir’s success will outlast AI exuberance | -2 | 3 | 05-11-2025 |
| 9 | Jim Cramer makes bold buy call on one booming energy stock | 7 | 6 | 04-07-2026 |
| 10 | Акции "Сегежа груп" на Мосбирже растут более чем на 5% на публикации отчетности | 0 | 0 | 02-11-2021 |